A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

Prior approvals of the PET imaging agent, including its initial FDA approval in December 2021, were supported by findings from 2 prospective clinical trials that included a total of 960 men with ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...

T2-weighted MRI is useful in the local staging of cancer and treatment planning in intermediate- and high-risk patients. It has good sensitivity rate for prostate cancer detection. Diffusion ...

The "Man Van" reached almost 3,500 men, 85% of whom showed up for scheduled screening exams. Almost 100 prostate cancers were ...

Prostate cancer is a significant health issue in India, with 37,000 new cases and 18,000 deaths annually. AI is ...

The Elekta Unity MR-LINAC system, used at Allegheny General Hospital, combines MRI imaging with radiation therapy to target ...

First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of ...

WVU Medicine St. Joseph’s Hospital is proud to announce the addition of two cutting-edge imaging services: PET/CT and ...

A VISION-like, Single-Center Analysis Predicting Outcomes of Indeterminate Bone Lesions on 18F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer PSMA-Directed ...